Preclinical safety assessment and immunological evaluation of xenogeneic mammary cells of porcine origin, utilized as an intralesional immunotherapeutic agent.

Saved in:
Bibliographic Details
Title: Preclinical safety assessment and immunological evaluation of xenogeneic mammary cells of porcine origin, utilized as an intralesional immunotherapeutic agent.
Authors: Liu LC; Department of Medicine and Department of Surgery, College of Medicine, China Medical University and Hospital, Taichung., Shyr CR; Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung.; eXCELL Biotherapeutics INC., Taichung., Lin TY; Urology Division, Department of Medicine, China Medical University and Hospital, Taichung., Wu CF; Urology Division, Department of Medicine, China Medical University and Hospital, Taichung., Shih CK; Urology Division, Department of Medicine, China Medical University and Hospital, Taichung., Ma WL; Graduate Institute of Biomedical Sciences, and PhD Program for Health Science and Industry, School of Medicine, China Medical University, Taichung., Yang CY; Animal Technology Research Center/Division of Animal Technology, Agriculture Technology Research Institute, Miaoli., Huang CP; Urology Division, Department of Medicine, China Medical University and Hospital, Taichung.
Source: Cell transplantation [Cell Transplant] 2026 Jan-Dec; Vol. 35, pp. 9636897251406337. Date of Electronic Publication: 2026 Mar 11.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9208854 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-3892 (Electronic) Linking ISSN: 09636897 NLM ISO Abbreviation: Cell Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1555-3892
DOI:10.1177/09636897251406337